...
首页> 外文期刊>Journal of Clinical Medicine >Prediction of Long-Term Outcomes in ST-Elevation Myocardial Infarction and Non-ST Elevation Myocardial Infarction with and without Creatinine Kinase Elevation—Post-Hoc Analysis of the J-MINUET Study
【24h】

Prediction of Long-Term Outcomes in ST-Elevation Myocardial Infarction and Non-ST Elevation Myocardial Infarction with and without Creatinine Kinase Elevation—Post-Hoc Analysis of the J-MINUET Study

机译:在j-minuet研究中与肌酐激酶升高 - HINUET研究中的肌酐激酶升高的长期结果预测在ST升高心肌梗死和非St升高心肌梗死

获取原文
           

摘要

Background: A Japanese prospective, nation-wide, multicenter registry (J-MINUET) showed that long-term outcomes were worse in non-ST elevation acute myocardial infarction (NSTEMI), diagnosed by increased cardiac troponin levels, compared to STEMI. This was observed in both non-STEMI with elevated creatine kinase (CK) (NSTEMI+CK) and non-STEMI without elevated CK (NSTEMI-CK). However, predictive factors for long-term outcomes in STEMI, NSTEMI+CK, and NSTEMI-CK have not been elucidated. Methods: Using the Cox proportional hazards model, we determined significant independent predictors of long-term outcomes from a total of 111 parameters evaluated in the J-MINUET study in each of our groups, including STEMI, NSTEMI+CK, and NSTEMI-CK. Then, we calculated the risk score using the regression coefficients for the determined independent predictors for the strict prediction of long-term outcomes. Results: Prognostic factors, as well as composite cardiovascular events and all-cause death, were different between STEMI, NSTEMI+CK, and NSTEMI-CK. Risk scores could effectively and powerfully predict both composite cardiovascular events and all-cause death in each group. Conclusions: The prediction of long-term outcomes using cored parameters of baseline demographics and clinical characteristics is feasible and could prove useful in establishing therapeutic strategies in patients with STEMI, NSTEMI+CK, and NSTEMI-CK.
机译:背景:日本前瞻性,全国范围内,多中心注册表(J-MINUET)显示,与茎的心肌肌钙蛋白水平增加,在非St升高急性心肌梗死(NSTEMI)中,长期结果较差。这在非茎的非茎秆中观察到,肌肉激酶(CK)(Nstemi + CK)和非茎,而无需升高CK(nstemi-ck)。然而,尚未阐明在stemi,nstemi + ck和nstemi-ck中长期结果的预测因素。方法:使用Cox比例危险模型,我们确定了在我们的每个群组中的J-MINUET研究中评估的111个参数的重要独立预测因子,包括STEMI,NSTEMI + CK和NSTEMI-CK。然后,我们计算使用所确定的独立预测因子的回归系数来严格预测长期结果的风险分数。结果:睾丸,NSTEMI + CK和NSTEMI-CK之间的预后因素以及复合心血管事件和全因死亡。风险评分可以有效地且有力地预测每组复合心血管事件和全因死亡。结论:使用基线人口统计学的核心参数和临床特征的长期结果预测是可行的,可以证明在患有STEMI,NSTEMI + CK和NSTEMI-CK患者中建立治疗策略。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号